Mettler-Toledo International (MTD) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
18 Mar, 2026Executive summary
The annual meeting is scheduled for May 7, 2026, with shareholders voting on director elections, auditor ratification, and executive compensation approval.
Shareholders of record as of March 9, 2026, are eligible to vote, with 20,248,505 shares outstanding.
Voting can be done online, by phone, mail, or in person, and a quorum requires a majority of outstanding shares.
Voting matters and shareholder proposals
Proposals include electing nine directors for one-year terms, ratifying PricewaterhouseCoopers LLP as auditor, and an advisory vote on executive compensation.
No additional business is anticipated, but proxies may vote on other matters as needed.
Shareholder proposals and director nominations for the next annual meeting must comply with specific timing and procedural requirements.
Board of directors and corporate governance
The board consists of nine independent directors, including an independent non-executive chair and a lead director.
Three standing committees: Audit, Compensation, and Nominating & Corporate Governance, all with independent members.
Annual board and committee self-evaluations, regular director refreshment, and mandatory retirement at age 72.
Proxy access and majority voting in uncontested elections are in place; no poison pill is in effect.
Directors must hold shares equal to five times their cash retainer within five years.
Latest events from Mettler-Toledo International
- Director elections, auditor ratification, and say-on-pay vote set for May 7, 2026.MTD
Proxy Filing18 Mar 2026 - Q4 2025 saw 8% sales and EPS growth, with a strong 2026 outlook despite market headwinds.MTD
Q4 20256 Feb 2026 - Q2 sales fell 4%, but margin gains and service growth led to raised full-year guidance.MTD
Q2 20242 Feb 2026 - Q3 adjusted EPS up 4% on 1% sales growth; Laboratory and Service led gains amid soft markets.MTD
Q3 202415 Jan 2026 - Manufacturing flexibility, innovation, and operational programs drive growth and margin expansion.MTD
Stifel 2024 Healthcare Conference13 Jan 2026 - Innovation, digitalization, and margin expansion fuel global growth and shareholder value.MTD
44th Annual J.P. Morgan Healthcare Conference13 Jan 2026 - Lab and service growth offset China industrial softness; cautious 2025 outlook with service focus.MTD
7th Annual Evercore ISI HealthCONx Conference11 Jan 2026 - Innovation, digitalization, and service drive growth, with margin expansion and 2025 recovery expected.MTD
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026 - Q4 2024 saw double-digit sales and EPS growth, with 2025 guidance reflecting ongoing headwinds.MTD
Q4 20248 Jan 2026